Uncu, D. Et Al. 2015. Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study. Asian Pacific Journal of Cancer Prevention , vol.16, no.9 , 4127-4131.

Uncu, D., Bayoglu, I. V., Arslan, U. Y., Kucukoner, M., Artac, M., Koca, D., ... Oguz, A.(2015). Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study. Asian Pacific Journal of Cancer Prevention , vol.16, no.9, 4127-4131.

Uncu, Dogan Et Al. "Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study," Asian Pacific Journal of Cancer Prevention , vol.16, no.9, 4127-4131, 2015

Uncu, Dogan Et Al. "Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study." Asian Pacific Journal of Cancer Prevention , vol.16, no.9, pp.4127-4131, 2015

Uncu, D. Et Al. (2015) . "Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study." Asian Pacific Journal of Cancer Prevention , vol.16, no.9, pp.4127-4131.

@article{article, author={Dogan Uncu Et Al. }, title={Trastuzumab-based retreatment after lapatinib in heavily pretreated HER2 positive metastatic breast cancer: An anatolian society of medical oncology study}, journal={Asian Pacific Journal of Cancer Prevention}, year=2015, pages={4127-4131} }